Histopathology of the vestibular end organs after intratympanic gentamicin failure for Meniere's disease

被引:19
|
作者
Ishiyama, Gail
Lopez, Ivan
Baloh, Robert W.
Ishiyama, Akira
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Surg, Div Head & Neck Surg, Los Angeles, CA 90095 USA
关键词
design-based unbiased stereology; human vestibular periphery; inner ear; vestibular hair cell; aminoglycoside; ototoxicity; morphometry;
D O I
10.1080/00016480600672600
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Conclusion: To our knowledge, this is the first report of the histopathology of the vestibular end organs following intratympanic gentamicin for intractable Meniere's disease. There was relative sparing of the utricular macula, compared with the cristae ampullares. However, the utricular macula exhibited severe hair cell loss. Clinically, the patient has been free from vertigo spells for 3 years following labyrinthectomy. Objective: To describe the histopathology and morphometry of the vestibular end organs from a 59-year-old Meniere's patient who underwent transmastoid labyrinthectomy for recurrent vertigo after failed intratympanic gentamicin. Materials and methods: Light and transmission electron microscopy were utilized; with unbiased stereology-physical fractionator for type I, type II hair cell, and supporting cell counts. Comparison with end organ histopathology in a 56-year-old with Meniere's disease without gentamicin treatment was carried out. Results: Histopathological analysis of the semicircular canal cristae ampullares showed severe atrophy of the neuroepithelium with undifferentiated cells, and fibrosis and edema of the stroma. The utricular macula had some remaining type I and type II vestibular hair cells, and nerve fibers and terminals within the underlying stroma. Morphometric measures were obtained from the utricular macula: 2000 type I and 500 type II hair cells, representing 7.3% of type I hair cells and 4.9% of type II hair cells compared with normative controls, and 24 000 supporting cells were obtained.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 50 条
  • [1] Update on intratympanic gentamicin for Meniere's disease
    Blakley, BW
    LARYNGOSCOPE, 2000, 110 (02) : 236 - 240
  • [2] Management of Intractable Meniere's Disease After Intratympanic Injection of Gentamicin
    Rah, Yoon C.
    Han, Jae J.
    Park, Jaehong
    Choi, Byung Y.
    Koo, Ja-Won
    LARYNGOSCOPE, 2015, 125 (04) : 972 - 978
  • [3] Intratympanic gentamicin in Meniere's disease: Results of therapy
    Murofushi, T
    Halmagyi, GM
    Yavor, RA
    AMERICAN JOURNAL OF OTOLOGY, 1997, 18 (01) : 52 - 57
  • [4] Intratympanic gentamicin compared with placebo for Meniere's disease
    de Amesti, Fernanda
    Santander, Maria Jesus
    Winter, Matias
    MEDWAVE, 2022, 22 (02):
  • [5] Treatment of Meniere's disease by intratympanic gentamicin application
    Assimakopoulos, D
    Patrikakos, G
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2003, 117 (01) : 10 - 16
  • [6] Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's Disease
    Martin, E
    Perez, N
    OTOLOGY & NEUROTOLOGY, 2003, 24 (05) : 800 - 806
  • [7] The Effect of Intratympanic Methylprednisolone and Gentamicin Injection on Meniere's Disease
    Gabra, Nathalie
    Saliba, Issam
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2013, 148 (04) : 642 - 647
  • [8] current opinion: Intratympanic gentamicin therapy for meniere's disease
    Bhattacharyya A.K.
    Indian Journal of Otolaryngology & Head and Neck Surgery, 1997, 49 (2) : 172 - 173
  • [9] Hearing outcome after gentamicin for intractable meniere's disease
    Verhoeven, S.
    Vanderveken, O. M.
    Van Rompaey, V.
    Van de Heyning, P.
    B-ENT, 2018, 14 (01) : 63 - 69
  • [10] Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Meniere's disease
    Perez, N
    Boleas, S
    Martin, E
    AUDIOLOGY AND NEURO-OTOLOGY, 2005, 10 (02) : 69 - 78